Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$398,029,053
+$66,576,686 QoQ
Shares Held
1,581,740
+3.8% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#98
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $5,636,745,309 across 13 Drug Manufacturers - General names. ABBV ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,141,447 | $2,568,515,989 | |
| 2 | JNJ |
Johnson & Johnson
|
2,620,929 | $665,637,338 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
10,168,924 | $585,933,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,143,885 | $532,489,222 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,581,740 | $398,029,053 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,203,012 | $278,328,536 | |
| 7 | AMGN |
Amgen Inc
|
632,302 | $228,969,200 | |
| 8 | PFE |
Pfizer Inc
|
9,152,541 | $220,393,187 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $398,029,053 | 1,581,740 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $331,452,367 | 1,523,989 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $345,031,324 | 1,510,050 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $353,244,833 | 1,525,632 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $260,822,454 | 1,405,142 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $299,486,840 | 1,429,395 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $334,941,576 | 1,884,871 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $384,848,826 | 1,948,799 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $362,742,673 | 2,114,871 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $383,523,905 | 2,106,117 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $302,949,613 | 1,954,892 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $255,437,414 | 1,713,655 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $230,578,942 | 1,711,415 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $280,457,094 | 1,759,786 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $361,098,798 | 2,234,384 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $303,896,937 | 2,264,339 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $363,514,998 | 2,373,433 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $453,013,152 | 2,794,480 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $351,806,028 | 2,598,272 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $255,314,590 | 2,366,873 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $238,260,858 | 2,115,242 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $172,067,202 | 1,589,976 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $157,999,532 | 1,474,564 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $132,450,357 | 1,512,163 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $150,465,071 | 1,532,543 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $140,550,588 | 1,844,738 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||